Sarepta Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Sarepta Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Sarepta Therapeutics Inc Strategy Report
- Understand Sarepta Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Sarepta Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20220280546A1 | Application | EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY | A61K31/712; A61K31/7125; A61K47/645; A61P21/00; C12N15/113; C12N2310/111 | September 08, 2022 |
EP3554554B1 | Grant | EXON-SKIPPING-OLIGOMERKONJUGATE FÜR MUSKELDYSTROPHIE | A61K31/7088; A61K47/549; A61K47/645; A61P21/00; C12N15/113; C12N2310/11; C12N2310/3233; C12N2310/3513; C12N2320/35 | September 07, 2022 |
NZ775701A | Application | Exon skipping compositions for treating muscular dystrophy | A61K31/7088; A61K31/713; A61K47/60; A61K47/6455; A61P21/00; A61P21/04; A61P43/00; C12N15/11; C12N15/111; C12N15/113; C12N2310/11; C12N2310/3233; C12N2310/33; C12N2310/351; C12N2310/3513; C12N2310/3535; C12N2320/30; C12N2320/33 | August 26, 2022 |
LT3554553T | Grant | EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY | A61K31/712; A61K31/7125; A61K47/645; A61P21/00; C12N15/113; C12N2310/111 | August 25, 2022 |
JP7125940B2 | Grant | 筋ジストロフィーに対するエクソンスキッピングオリゴマーコンジュゲート | A61K31/7088; A61K47/549; A61K47/645; A61P21/00; C12N15/113; C12N2310/11; C12N2310/3233; C12N2310/3513; C12N2320/35 | August 25, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward